Data-driven insights and AI can reduce clinical development risk and improve quantitative rigor in portfolio strategy. Panelists will share how they’ve used AI and insights tools to validate and calibrate the probability of technical and regulatory success (PTRS), support asset prioritization, and inform pipeline performance and strategic decisions about asset development.
Speakers:
- John McGrath — Course Director MSc Project Management, Technological University Dublin
- Ivan Kugener, MD — VP Head of Global Portfolio Management, Valuation & Analytics, EMD Serono
- Josh Hattem, MBA — Principal, Portfolio Strategy Practice Lead, ZS
- Panos Karelis, M.Eng., MSc — Director of Customer Experience & Insights, Intelligencia AI
Live Webcast: Elevate and De-Risk Your Drug Portfolio Strategy With AI Wednesday, August 28, 2024 at 11:00 am EST
